Module 1.2.2 (Management of OA) Flashcards Preview

IPT 3 Lectures > Module 1.2.2 (Management of OA) > Flashcards

Flashcards in Module 1.2.2 (Management of OA) Deck (15)
Loading flashcards...
1
Q

What are the signs and symptoms of OA? What are the most commonly affected joints?

A
  • Gradual onset, involving few joints
  • Most commonly affects DIP, PIP,first CMC joints, knees, hips, cervical and lumbar spine
  • Unilateral
  • Joint pain- worsened by activity, relieved by rest
  • Limited morning stiffness
  • Reduced joint movement and crepitus –> crackling noise when joint is moved
  • Joint swelling
  • Bony enlargement:

> Herberden’s nodes (on DIP)

> Bouchard’s nodes (on PIP)

2
Q

How to diagnose OA? Why are X-rays and blood tests not used for diagnosis? What other purpose do X-rays and blood test have in OA?

A

Diagnosis often based on history, symptoms and physical examination of affected joint(s)

  • X-ray and blood fests not used for diagnosis as the results do not change management or treatment
  • Blood test helpful if DR wants to rule out RA
  • X-ray used for uncertain diagnosis and exlude other joint disorders
3
Q

Difference between OA and RA:

A) Age of onset

B) Distribution of joints

C) Joint affected

D) ESR (marker of inflammation)

E) Rheumatoid factor

F) Systemic symptoms

A

A)

OA: later

RA: younger

B)

OA: unilateral

RA: symmetrical

C)

OA: DIP, PIP, first CMC joints, knees, hips, cervical and lumbar spine

RA: PIP, MCP, MTP; DIP joints spared

D)

OA: Normal or elevated

RA: Elevated (due to being an autoimmune disorder)

E)

OA: Absent

RA: Present (due to being an autoimmune disorder)

F)

OA: Absent

RA: Present (extra-articular symptoms)

4
Q

What are the aims of treatment in OA?

A
  • Reduce pain
  • Increase mobility
  • Reduce disability
5
Q

What are the aims of non-drug treatment in OA?

A
  • Weight reduction „
  • Physiotherapy, exercise, hydrotherapy „
  • Rest „
  • OT „
  • Self management strategies
6
Q

What are the THREE main types of drug treatment used in OA?

A
  1. Paracetamol or topical NSAIDs or topical capsaicin
  2. Oral NSAIDs
  3. Intra-articular injections (injection into joints affected by OA)
7
Q

What is the dosage for 1. Paracetamol or topical NSAIDs or topical capsaicin used in OA

A

Paracetamol ƒ

  • Limited pain relief if used alone in tx of OA (variable between individual) ƒ
  • Dose: 1g qid or 1330mg SR tds

Topical NSAIDs

  • Include diclofenac, ibuprofen and piroxicam
  • To be applied up to 4 times daily

Topical capsaicin

  • To be applied up to 4 times daily
8
Q

When is 2. Oral NSAIDs used in OA?

A
  • Moderate to severe OA
  • Superior to paracetamol
9
Q

For 3. intraarticular injections (steroids);

A) How long do they provide relief for in knee OA

B) Name FOUR examples

C) Max number of injections administered into a single joint in a year?

D) When to stop using injections

A

A)

  • Short term pain relief - a single injection provides up to 8 weeks (4-12 weeks) relief in pain in knee OA

B)

  • Includes triamcinolone, betamethasone, dexamethasone, methylprednisolone

C)

  • No > 4 injections should be administered to a single joint in a year

D)

  • Avoid further injections if there is no response after two consecutive injections
10
Q

For 3. intraarticular injections (hyaluronic acid);

A) How is it given

B) What does it do? How long does its effects last?

C) Comparison to intraarticular corticosteroid

A

A)

  • Given as a single injection or as a weekly injection for 3 to 5 weeks depending on the formulation

B)

  • Relief pain, swelling, and stiffness up to six months in knee OA

C)

  • Expensive and slower onset of action but longer duration of pain relief compared to intraarticular corticosteroid
11
Q

For 3. intraarticular injections (regenerative);

A) What is it?

A
  • platelet-rich plasma (PRP), adipocyte cell suspensions or mesenchymal stem cell injections
12
Q

What are the two complementary medicines used in OA? Provide details such as doses and cautions.

A

Glucosamine

  • Dose: 1.5g daily (available as sulfate or HCl salt)
  • Sulfate salt shown to be more effective
  • Conflicting evidence on efficacy

Caution:

> Shellfish allergy „

> Impaired glucose tolerance „

> Anticoagulant tx (affects INR)

Chondroitin

  • Dose: 800-1200mg daily
  • Shown to be as effective as glucosamine

Caution:

> Antiocoagulant Tx (affects INR)

13
Q

When is surgery (arthroplasty) used for OA?

A
  • Do not respond to other tx
  • Function in the joint significantly impaired
  • X-ray evidence of joint damage

> Mostly indicated for hip and knee OA

14
Q

Provide an outline/algorithm of the Tx in OA starting off with non-pharmacological management

A
  1. Non pharmacological management +
  2. Topical NSAIDs or capsaicin (first line) +/-
  3. paracetamol 1g orally 4-6 hourly as necessary, upto max of 4g daily OR paracetamol modified-release 1.33g orally, 8 hourly as necessary OR an NSAID orally +/-

> NSAID only if patients at low risk of NSAID

> If at high risk = first-line treatment is topical NSAID/capsaicin + paracetamol

  1. IA corticosteroid or hyaluronic acid injection +/-
  2. Glucosamine or Chondroitin
15
Q

Provide a summary for OA

A
  • OA is a degenerative joint disease characterised by progressive loss of articular cartilage
  • Management of OA include non pharmacological interventions and pharmacological treatment to reduce pain and improve functionality
  • Pharmacological treatment include analgesic (paracetamol, oral and topical NSAIDs, topical capsaicin) and intra-articular injections (steroids, hyaluronic acid injection )
  • Glucosamine and chondroitin supplementation are shown to reduce pain in certain patients albeit limited evidence
  • Surgery can be an option in patient refractive to above treatments